Sensor Enabled Chronic Respiratory Patient Care Market, 2022: Disease Demographics / Morbidities and Mortality / Patient Care Market Drivers / Remote Patient Monitoring / Risk Factors

Converging technologies are creating new ways for patients diagnosed with chronic upper respiratory illnesses to improve outcomes while avoiding external factors that may exacerbate or trigger their conditions.
Comunicato Precedente

next
Comunicato Successivo

next
Preferisci Informazione.News su Google

Converging technologies are creating new ways for patients diagnosed with chronic upper respiratory illnesses to improve outcomes while avoiding external factors that may exacerbate or trigger their conditions.

These complementary patient care modalities, most of which are in the early stages of adoption, hold the capability to move treatment for COPD and asthma beyond responsive dosing to predictive behaviors and avoidance over the next five years. Much of the activity and media coverage have centered on electronics - in particular, sensors that can be attached to oral inhalers to provide data capture of user dosing and adherence to drug protocols.

The incorporation of wireless technologies allows this data to be sent, typically via smartphone, off-device to the caregiver, a third-party data response team or an mHealth cloud for processing via analytics and re-direction to the patients EHR file. These advances are now being joined - often combined - with technologies that include portable wireless spirometers, geographic proximity air quality monitors, acoustic-enabled condition diagnostics, and more exotic approaches that include breath analysis, breathing/speech monitoring and patient baselining.

The most active collaborations have been between digital device developers and suppliers of air quality data. This is a straightforward progression in the evolution of technology-enabled inhalers and can be considered the low-hanging fruit in the ongoing effort to further enable asthma and COPD patients to improve the control of their symptoms.

What You Will Learn

Key Topics Covered:

1. Executive Summary

2. Chronic Respiratory Patient Care

3. Market Segments and Indications

4. Respiratory Care Design Initiatives

5. Product Factors

6. Sensor Data Connectivity

7. Product Assessment & Analysis

8. Therapeutic Segment Analysis, Market Usage Data & Forecasts

9. Market Factors

10. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/cxmxrk/sensor_enabled?w=5

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Per maggiori informazioni

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;